Evidence map›Paper›PMID 25673810›Full record

ArticleAmerican journal of physiology. Renal physiology2015

Role of spinal metabotropic glutamate receptor 5 in pudendal inhibition of the nociceptive bladder reflex in cats.

Jeremy N Reese, Marc J Rogers, Zhiying Xiao, Bing Shen, Jicheng Wang, Zeyad Schwen, James R Roppolo, William C de Groat, Changfeng Tai

Abstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Pathways and parameters of sacral neuromodulation in rats.American journal of physiology. Renal physiology · 2023
    Article
  2. Review
  3. Article
  4. Neurotransmitter Mechanisms Underlying Sacral Neuromodulation of Bladder Overactivity in Cats.Neuromodulation : journal of the International Neuromodulation Society · 2017
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Jeremy N ReeseDepartment of Urology, University of Pittsburgh, Pittsburgh, Pennsylvania;
Marc J RogersDepartment of Urology, University of Pittsburgh, Pittsburgh, Pennsylvania;
Zhiying XiaoDepartment of Urology, University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Urology, The Second Hospital, Shandong University, Jinan, People's Republic of China; and.
Bing ShenDepartment of Urology, University of Pittsburgh, Pittsburgh, Pennsylvania;
Jicheng WangDepartment of Urology, University of Pittsburgh, Pittsburgh, Pennsylvania;
Zeyad SchwenDepartment of Urology, University of Pittsburgh, Pittsburgh, Pennsylvania;
James R RoppoloDepartment of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania.
William C de GroatDepartment of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania.
Changfeng TaiDepartment of Urology, University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania cftai@pitt.edu.
University of Pittsburgh · US

Funding

Bladder Nociception: function/central projection of Sympathetic Afferent PathwayR01DK091253 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DEGROAT, WILLIAM C · 2011 to 2015
$1.7M
Neurotransmitter Receptors Involved in Neuromodulation of Bladder OveractivityR01DK102427 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI TAI, CHANGFENG · 2014 to 2017
$924k
Central Sites of Action for Bladder NeuromodulationR01DK094905 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI TAI, CHANGFENG · 2013 to 2016
$922k
New Strategies to Treat Overactive BladderR01DK090006 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI TAI, CHANGFENG · 2010 to 2013
$781k
NIDDK NIH HHS DK-090006NIDDK NIH HHS DK-091253NIDDK NIH HHS DK-094905NIDDK NIH HHS DK-102427NIDDK NIH HHS R01 DK090006NIDDK NIH HHS R01 DK091253NIDDK NIH HHS R01 DK094905NIDDK NIH HHS R01 DK102427
6 · The paper itself

Abstract

This study examined the role of spinal metabotropic glutamate receptor 5 (mGluR5) in the nociceptive C-fiber afferent-mediated spinal bladder reflex and in the inhibtion of this reflex by pudendal nerve stimulation (PNS). In α-chloralose-anesthetized cats after spinal cord transection at the T9/T10 level, intravesical infusion of 0.25% acetic acid irritated the bladder, activated nociceptive C-fiber afferents, and induced spinal reflex bladder contractions of low amplitude (<50 cmH2O) and short duration (<20 s) at a smaller bladder capacity ∼80% of saline control capacity. PNS significantly (P < 0.01) increased bladder capacity from 85.5 ± 10.1 to 137.3 ± 14.1 or 148.2 ± 11.2% at 2T or 4T stimulation, respectively, where T is the threshold intensity for PNS to induce anal twitch. MTEP {3-[(2-methyl-4-thiazolyl)ethynyl]pyridine; 3 mg/kg iv, a selective mGluR5 antagonist} completely removed the PNS inhibition and significantly (P < 0.05) increased bladder capacity from 71.8 ± 9.9 to 94.0 ± 13.9% of saline control, but it did not change the bladder contraction amplitude. After propranolol (3 mg/kg iv, a β1/β2-adrenergic receptor antagonist) treatment, PNS inhibition remained but MTEP significantly (P < 0.05) reduced the bladder contraction amplitude from 18.6 ± 2.1 to 6.6 ± 1.2 cmH2O and eliminated PNS inhibition. At the end of experiments, hexamethonium (10 mg/kg iv, a ganglionic blocker) significantly (P < 0.05) reduced the bladder contraction amplitude from 20.9 ± 3.2 to 8.1 ± 1.5 cmH2O on average demonstrating that spinal reflexes were responsible for a major component of the contractions. This study shows that spinal mGluR5 plays an important role in the nociceptive C-fiber afferent-mediated spinal bladder reflex and in pudendal inhibition of this spinal reflex.

Indexed as

Neural InhibitionNociceptionReflexAcetic AcidAction PotentialsAnimalsCatsDisease Models, AnimalExcitatory Amino Acid AntagonistsFemaleMaleMuscle ContractionMuscle, SmoothNerve Fibers, UnmyelinatedNociceptorsPudendal Nerve3-((2-methyl-1,3-thiazol-4-yl)ethynyl)pyridineAcetic AcidExcitatory Amino Acid AntagonistsPyridinesReceptor, Metabotropic Glutamate 5Thiazolesbladdercatglutamateneuromodulationpudendal

Identifiers

PMID25673810
PMCPMC4398836
OpenAlexW2325966816

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.